SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MARCHETTI, Giovanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.353
AS - Asia 7.580
EU - Europa 4.076
SA - Sud America 1.174
Continente sconosciuto - Info sul continente non disponibili 215
AF - Africa 168
OC - Oceania 15
Totale 27.581
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.997
SG - Singapore 2.769
CN - Cina 1.951
BR - Brasile 916
VN - Vietnam 900
DE - Germania 891
UA - Ucraina 757
HK - Hong Kong 616
IT - Italia 564
TR - Turchia 458
GB - Regno Unito 413
SE - Svezia 265
FI - Finlandia 252
FR - Francia 240
RU - Federazione Russa 214
JP - Giappone 188
BD - Bangladesh 186
CA - Canada 181
PL - Polonia 159
IN - India 139
MX - Messico 124
AR - Argentina 87
ID - Indonesia 75
NL - Olanda 67
ZA - Sudafrica 62
IQ - Iraq 53
BE - Belgio 48
EC - Ecuador 47
ES - Italia 46
PK - Pakistan 37
CO - Colombia 34
CZ - Repubblica Ceca 34
MA - Marocco 30
UZ - Uzbekistan 30
VE - Venezuela 26
CL - Cile 22
LT - Lituania 22
PH - Filippine 21
SA - Arabia Saudita 21
MY - Malesia 20
PY - Paraguay 19
KE - Kenya 18
IE - Irlanda 17
TN - Tunisia 15
AT - Austria 14
NP - Nepal 13
AU - Australia 12
IR - Iran 12
JO - Giordania 12
UY - Uruguay 12
TW - Taiwan 11
AE - Emirati Arabi Uniti 10
IL - Israele 10
JM - Giamaica 10
PT - Portogallo 10
CR - Costa Rica 9
PE - Perù 9
EG - Egitto 8
RO - Romania 8
CH - Svizzera 7
DZ - Algeria 7
AL - Albania 6
AZ - Azerbaigian 6
KZ - Kazakistan 6
PS - Palestinian Territory 6
TT - Trinidad e Tobago 6
ET - Etiopia 5
OM - Oman 5
RS - Serbia 5
SN - Senegal 5
BG - Bulgaria 4
CI - Costa d'Avorio 4
EU - Europa 4
GR - Grecia 4
LV - Lettonia 4
PA - Panama 4
DO - Repubblica Dominicana 3
GT - Guatemala 3
HU - Ungheria 3
LB - Libano 3
MT - Malta 3
NG - Nigeria 3
NI - Nicaragua 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BW - Botswana 2
BY - Bielorussia 2
EE - Estonia 2
HN - Honduras 2
KG - Kirghizistan 2
KH - Cambogia 2
KR - Corea 2
KW - Kuwait 2
LK - Sri Lanka 2
Totale 27.340
Salva come PNG Salva come JPEG
Città #
Singapore 1.715
Ashburn 1.394
Fairfield 1.044
Woodbridge 1.044
San Jose 989
Chandler 780
Jacksonville 774
Houston 770
Santa Clara 636
Ann Arbor 623
Hong Kong 600
Beijing 572
Seattle 443
Wilmington 410
Cambridge 378
Dallas 360
Ho Chi Minh City 293
Izmir 259
Nanjing 244
New York 239
Los Angeles 223
Munich 218
Hanoi 212
Council Bluffs 184
Tokyo 181
Boardman 180
Princeton 171
Warsaw 150
Lauterbourg 143
The Dalles 139
Ferrara 136
San Diego 112
Buffalo 97
São Paulo 96
Milan 94
Mexico City 87
Shanghai 84
Orem 78
Nanchang 70
Shenyang 69
Dearborn 63
Bremen 62
Tianjin 62
London 61
Toronto 61
Hebei 57
Helsinki 57
Turku 54
Hefei 52
Montreal 47
Frankfurt am Main 46
Brussels 45
Düsseldorf 45
San Mateo 45
Jakarta 44
Jiaxing 44
Changsha 43
Chennai 40
Chicago 40
Falkenstein 38
Falls Church 38
Brooklyn 37
Da Nang 37
Haiphong 36
Jinan 34
Johannesburg 33
Moscow 33
Rome 33
Denver 32
Amsterdam 31
Kunming 31
Norwalk 29
Rio de Janeiro 29
Addison 28
Redwood City 28
Tashkent 28
Brno 27
Manchester 27
Belo Horizonte 26
San Francisco 26
Atlanta 25
Guangzhou 24
Stockholm 24
Baghdad 23
Boston 23
Auburn Hills 22
Phoenix 22
Des Moines 21
Nuremberg 21
Zhengzhou 20
Biên Hòa 19
Florence 19
Mountain View 19
Philadelphia 19
Curitiba 18
Hải Dương 18
Columbus 17
Washington 17
Augusta 16
Bắc Ninh 16
Totale 18.323
Salva come PNG Salva come JPEG
Nome #
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 364
Are Plasma Levels of Vascular Adhesion Protein-1 Associated Both with Cerebral Microbleeds in Multiple Sclerosis and Intracerebral Haemorrhages in Stroke? 326
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis 309
VITAMIN K-INDUCED MODIFICATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY 260
Hemostasis biomarkers in multiple sclerosis 260
A De Novo and Heterozygous Gene Deletion Causing a Variant of von Willebrand Disease 258
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 256
U1snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 254
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease 252
A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects 251
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 249
Calmodulin expression distinguishes the smooth muscle cell population of human carotid plaque 248
Genetic determinants of activated factor VII antithrombin complex plasma concentration include tissue factor, factor VII and endothelial protein C receptor gene variants 248
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 246
Membrane binding and anticoagulant properties of protein S natural variants 242
A "de novo" Gene Deletion and New RFLPs Detected by von Willebrand Factor cDNA. 235
A DE NOVO GENE ALTERATION CAUSING VON WILLEBRAND DISEASE 231
c-myc oncogene alterations in human thyroid carcinomas. 227
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 224
Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile 223
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 222
The effectiveness of Robot-Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): Study protocol for a randomized controlled trial 222
Effective hemostasis during minor surgery in a case of hereditary combined deficiency of vitamin K-dependent clotting factors 219
Calmodulin Is a Marker of a Distinct Smooth Muscle Cell Population Recruited by Plaque-Derived Macrophages from the Human Carotid Artery Media 213
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 212
FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers 212
The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease 211
Characterization of polymorphic markers in the von Willebrand factor gene and pseudogene 205
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domain 204
Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala(223)Val MTHFR) in patients with inherited thrombophilic coagulation defects 203
Plasma levels of soluble NCAM in multiple sclerosis 203
Organization of α-Globin Genes and mRNA Translation in Subjects Carrying Haemoglobin Hasharon (α47 Asp → His) from the Ferrara Region (Northern Italy) 201
A family study of FVII genotype, elevated levels of factor VII and arterial thrombotic disease 201
Human protein S circulates in plasma partially bund to LDL and HDL: do PS-lipoprotein complexes mediate PS delivery within atherosclerotic plaque? 200
Factor VII mutant V154G models a zymogen-like form of factor VIIa 199
The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis 199
Interaction of occupational posture, lifestyle and genetic components of thrombophilia 198
A polymorphism in the 5′ region of coagulation factor VII gene (F7) caused by an inserted decanucleotide 196
A RECURRENT AMINOACID SUBSTITUTION AND A PARTIAL GENE DELETION IN SEVERE HEMOPHILIA A 196
Expression profiles of the internal jugular and saphenous veins: Focus on hemostasis genes 196
Partial gene deletion in a family with factor X deficiency 195
Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes 195
Characterization of PAR-mediated signaling induced by activated coagulation factor X mutants 193
An Italian Family with a Novel Mutation Causing Type 2A von Willebrand Disease and with Reduced Levels of von Willebrand Factor not Linked with the von Willebrand Factor Gene. 192
CHARACTERIZATION OF THE PSEUDOGENIC REGION OF VON WILLEBRAND FACTOR BY MOLECULAR CLONING AND "IN SITU" HYBRIDIZATION 190
alpha-Thalassemia trait in the region of Ferrara. 190
Human leukemia K562 cells: Relationship between hemin-mediated erythroid induction, cell proliferation and expression of c-abl and c-myc oncogenes 188
Characterization of the intracellular signalling capacity of natural FXa mutants with reduced pro-coagulant activity 188
Modulation of factor VII levels by intron 7 polymorphisms: Population and in vitro studies 187
Molecular mechanisms of FVII deficiency: Expression of mutations clustered in the IVS7 donor splice site of factor VII gene 186
Factor XII gene alteration in Hageman trait detected by TaqI restriction enzyme 183
Functional recovery in multiple sclerosis patients undergoing rehabilitation programs is associated with plasma levels of hemostasis inhibitors 183
How to evaluate phenotype-genotype relationship in rare coagulation haemorrhagic disorders: examples from FVII deficiency 180
Deletion of exons 26-34 (domain D3-A3) of von Willebrand-factor gene in the von Willebrand disease type-II. 180
Taqi polymorphism at the human coagulation factor XII locus (F12) 179
Characterization and mapping of the 5′ portion of von Willebrand factor pseudogene 178
Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII 178
Rapid detection of a protein C gene mutation present in the asymptomatic and not in the thrombosis‐prone lineage 177
CHROMOSOMAL LOCALIZATION AND CHARACTERIZATION OF RFLPs IN THE VON WILLEBRAND FACTOR PSEUDOGENE 175
Detection of new polymorphic markers in the factor V gene: Association with factor V levels in plasma 174
Two taqI RFLPs in the human von willebrand factor gene 171
Angiotensin-converting enzyme gene polymorphism made risk of restenosis after coronary stenting 170
Localization of cloned human DNA sequences and analysis of chromosomal alteration by in situ hybridization 169
PRIMARY INTRAVASCULAR SYNOVIAL SARCOMA OF THE FEMORAL VEIN IN A MALE PATIENT, CASE REPORT 168
Impaired prothrombinase activity of factor X Gly381 Asp results in severe familial CRM+ FX deficiency 168
Molecular genetics and biology of congenital hemorrhagic diseases 167
Two additional TaqI RFLPs in von willebrand factor gene (VWF) and pseudogene 167
Protein S on the surface of plasma lipoproteins: a potential mechanism for protein S delivery to the atherosclerotic plaques? 166
Detection and characterization of polymorphic markers in the factor-VII gene. 166
Symptomatic type II protein C deficiency caused by a missense mutation (Gly 381-->Ser) in the substrate-binding pocket 166
In-Frame Deletion of von Willebrand Factor Exons 26-34 (D3-A3 Domains) in Type II von Willebrand Disease. 165
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 165
A HIND III RFLP AND A GENE LESION IN THE COAGULATION FACTOR-VIII GENE 165
New coagulation factor V gene polymorphisms define a single and infrequent haplotype underlying the factor V leiden mutation in Mediterranean populations and Indians 164
The Gly331Ser mutation in factor VII in Europe and the Middle East 163
Factor V markers for the detection of genetic components of APC resistance in venous thrombosis 163
Baseline and overtime variations of soluble adhesion molecule plasma concentrations are associated with mobility recovery after rehabilitation in multiple sclerosis patients 162
Hemostasis gene expression of the internal jugular and saphenous veins 159
Caratterizzazione di una nuova mutazione nell’esone 28 del gene del fattore di von Willebrand (FvW) responsabile della malattia di vW di tipo IIA. 158
Sublocalization of von Willebrand Factor Pseudogene in 22q11.22-q11.23 and Detection of two TaqI RFLPs. 157
Modulation of FVII levels by intron 7 polymorphisms: population and in vitro studies 156
Study of a G/A variation in the 3' untranslated region of prothrombin mRNA in Italian patients with venous thrombosis 156
Alterazione genica "de novo" in una variante della malattia di von Willebrand. 156
A FREQUENT FACTOR-XII GENE MUTATION IN HAGEMAN TRAIT 154
Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7) 154
Hyperhomocysteinemia and a common methylene-tetrahydrofolate reductase mutation (Ala223Val MTHFR) are not associated with a history of thrombosis in patients with inherited thrombophilia 153
Soluble neural cell adhesion molecule and behavioural recovery in minimally conscious patients undergoing transcranial direct current stimulation 153
Non-conventional therapeutic strategies for inherited disorders of hemostasis 152
Identification of a c-myc oncogene lacking the exon 1 in the normal cells of a patient carrying a thyroid carcinoma 152
CCL18 plasma levels are increased in progressive MS patients and associated with MRI outcomes of tissue injury (P1.396) 152
Increased CCL18 plasma levels are associated with neurodegenerative MRI outcomes in multiple sclerosis patients 152
Factor V markers for the detection of genetic components of APC resi stance in venous thrombosis. 151
Reduced activation of the Gla19Ala FX variant via the extrinsic coagulation pathway results in symptomatic CRMred FX deficiency 150
Risks factors for highly unstable response to oral anticoagulation: a case-control study 150
Novel phenotype and gamma-glutamyl carboxylase mutations in combined deficiency of vitamin K-dependent coagulation factors 150
Decay of β-globin synthesis in heterozygous β 0 Ferrara thalassaemia 149
Oral contraceptives highlight the genotype-specific association between serum phospholipids and activated factor VII 149
Plasma levels of protein C pathway proteins and brain magnetic resonance imaging volumes in multiple sclerosis 149
Contribution of asialoglycoprotein receptor ASGR2 5’ UTR polymorphisms to full-length FVIII concentrate pharmacokinetics 149
PCR and specific oligonucleotide hybridization for the molecular characterization and carrier detection of hemophilia A. 148
Totale 19.300
Salva come PNG Salva come JPEG
Categoria #
all - tutte 124.280
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.134
Totale 125.414
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.711 0 191 130 111 114 64 73 80 53 129 153 613
2022/20231.766 189 123 45 215 282 289 74 165 221 14 91 58
2023/2024924 69 91 34 32 64 191 20 62 23 20 24 294
2024/20253.496 93 66 295 99 468 299 78 173 507 479 536 403
2025/202610.288 974 410 1.066 1.331 1.495 707 1.306 507 941 966 367 218
2026/2027482 241 241 0 0 0 0 0 0 0 0 0 0
Totale 27.581